Pentagastrin is a synthetic pentapeptide that has effects like gastrin. When given parenterally it stimulates the secretion of gastric acid, pepsin and intrinsic factor.
CAT No: 10-101-95
CAS No:5534-95-2
Synonyms/Alias:pentagastrin;5534-95-2;Peptavlon;Pentagastrina;Pentagastrine;Gastrodiagnost;Pentagastrinum;Petogasrin;ICI-50123;AY 6608;AY-6608;ICI 50123;ICI 50,123;UNII-EF0NX91490;DTXSID3048992;HSDB 3247;EF0NX91490;Boc-beta-ala-try-met-asp-phe(nh2);EINECS 226-889-7;MFCD00076515;NSC 367746;NSC-367746;Pentagastrine [INN-French];Pentagastrinum [INN-Latin];BRN 5472892;CHEMBL1328;Pentagastrina [INN-Spanish];DTXCID9028918;L-Phenylalaninamide, N-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-;Pentagastrine (INN-French);Pentagastrinum (INN-Latin);N-Carboxy-beta-alanyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide N-tert-butyl ester;N-t-Butyloxycarbonyl-beta-alanyl-L-tryptophyl-L-methion yl-L-aspartyl-L-phenylalanine amide;Pentagastrina (INN-Spanish);PENTAGASTRIN (MART.);PENTAGASTRIN [MART.];Alaninamide, N-carboxy-beta-alanyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-, N-tert-butyl ester, L-;N-(alpha-Carbamoylphenethyl)-3-(2-(2-(3-(carboxyamino)propionamido)-3-indol-3-ylpropionamido)-4-(methylthio)butyramido)succinamic acid N-tert-butyl ester;N-(N-(N-(N-(N-tert-Butoxycarbonyl-beta-alanyl)-L-tryptophanyl)-L-methionyl)-L-aspartyl)-L-phenylalaninamide;(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid;Alaninamide, N-carboxy-beta-alanyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-, N-tert-butylester, L-;Gastrin Pentapeptide;CAS-5534-95-2;Pentapeptide, Gastrin;Peptavlon (TN);Pentagastrin [USAN:INN:BAN:JAN];PETAVLON;PENTAGASTRIN [MI];PENTAGASTRIN [INN];PENTAGASTRIN [JAN];PENTAGASTRIN [HSDB];PENTAGASTRIN [USAN];PENTAGASTRIN [VANDF];SCHEMBL26045;MLS006009992;PENTAGASTRIN [WHO-DD];Pentagastrin (JAN/USAN/INN);CHEBI:31974;V04CG04;NEYNJQRKHLUJRU-DZUOILHNSA-N;PENTAGASTRIN [ORANGE BOOK];EX-A7390;HY-A0261;Boc-beta-Ala-Trp-Met-Asp-Phe-NH2;Tox21_113479;BDBM50024321;AKOS030213248;Tox21_113479_1;CS-5667;DB00183;N-(ALPHA-CARBAMOYLPHENETHYL)-3-;NCGC00167300-01;NCGC00183362-01;NCGC00183362-02;AS-56396;DA-76711;N-t-Boc-beta-Ala-Trp-Met-Asp-Phe amide;SMR004701067;NS00043181;D01631;EN300-19736421;Q423586;BRD-K78789465-001-01-6;BRD-K78789465-001-02-4;(10S,13S,16S)-10-((1H-indol-3-yl)methyl)-16-((S)-1-amino-1-oxo-3-phenylpropan-2-ylcarbamoyl)-2,2-dimethyl-13-(2-(methylthio)ethyl)-4,8,11,14-tetraoxo-3-oxa-5,9,12,15-tetraazaoctadecan-18-oic acid;(3S)-3-[(2S)-2-[(2S)-2-(3-{[(tert-butoxy)carbonyl]amino}propanamido)-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid;226-889-7;3-{2-[2-(3-tert-Butoxycarbonylamino-propionylamino)-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid;L-PHENYLALANINAMIDE, N-((1,1-DIMETHYLETHOXY)CARBONYL)-.BETA.-ALANYL-L-TRYPTOPHYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-;N-CARBOXY-.BETA.-ALANYL-L-TRYPTOPHYL-L-METHIONYL-L-ASPARTYLPHENYL-L-ALANINAMIDE N-TERT-BUTYL ESTER;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More